FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

4038211000001106: Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
134151000001110 Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
134161000001113 Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Is a Product containing precisely metyrapone 250 milligram/1 each conventional release oral capsule true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has excipient Paraben and/or paraben derivative false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has active ingredient Metyrapone false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has manufactured dose form Capsule false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Is a Metopirone true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has excipient Hydroxybenzoates false Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has specific active ingredient Metyrapone true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Has manufactured dose form Conventional release oral capsule true Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) 100 capsule Is pack of False Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Inferred relationship Existential restriction modifier
Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) 100 capsule Has AMP True Metopirone 250mg capsules (HRA Pharma UK & Ireland Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start